![](/img/cover-not-exists.png)
A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer
Lavie, Ofer, Edelman, David, Levy, Tally, Fishman, Ami, Hubert, Ayala, Segev, Yakir, Raveh, Eli, Gilon, Michal, Hochberg, AvrahamVolume:
295
Language:
english
Journal:
Archives of Gynecology and Obstetrics
DOI:
10.1007/s00404-017-4293-0
Date:
March, 2017
File:
PDF, 650 KB
english, 2017